Tag: genomics
-
Nanotech Crispr Delivery in Development
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment.
-
Moderna Funding University Immunology Research
A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders.
-
23andMe, TrialSpark Partner on Clinical Trial Recruiting
A new collaboration of a genetics testing company with a clinical study site contractor aims to broaden and speed-up enrolling individuals in clinical trials.
-
Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-
Gel, Crispr Help Defeat Cancer Drug Obstacles
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells.
-
Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-
Response by Patients Shown to Precision Lung Cancer Drug
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition.
-
Spin-Off Licensing Athletic Microbiome Technology
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics.
-
Companies Call for Genome Editing Regulations
A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine.
-
Crispr Deployed for Programmable Smart Hydrogels
Bio-engineers developed a process using the gene editing technique Crispr to design gel materials with properties added for drug delivery, diagnostics, and electronic circuits.